Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
37.65 CHF | -0.26% | +5.76% | +6.66% |
Evolution of the average Target Price on Basilea Pharmaceutica AG
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Basilea Pharmaceutica AG
Edward Jones |
EPS Revisions
- Stock
- Equities
- Stock Basilea Pharmaceutica AG - Swiss Exchange
- Consensus Basilea Pharmaceutica AG